Fig. 3 | Scientific Reports

Fig. 3

From: Targeting the proliferation of glioblastoma cells and enhancement of doxorubicin and temozolomide cytotoxicity through inhibition of PFKFB4 and HMOX1 genes with siRNAs

Fig. 3

mRNA knockdown efficacy of siRNA treatments, as measured by qPCR. This figure demonstrates the silencing efficacy of siRNA treatments, with strong mRNA-to-protein correlation supported by prior studies. While protein-level validation was not performed due to resource constraints, qPCR results provide reliable evidence of knockdown efficacy.

Back to article page